Flora Southey
Editor at Food Navigator
A travelling journalist hunting down the world's best croissant. Views are mine. Pastry recommendations are yours. London | Montpellier | Melbourne
Articles
-
3 weeks ago |
foodnavigator.com | Donna Eastlake |Augustus Bambridge-Sutton |Flora Southey
The hybrid food market is emboldened, with milks, meats and cheeses available in supermarkets across the world. And the category is showing strong opportunity for growth, with hybrid meat holding a global market value of $2.5bn (Future Market Insights), and hybrid dairy of $10.9m (Fact.MR). So promising is the segment’s future that established brands like Kerry and St Paul are moving at pace into hybrid cheese arena.
-
3 weeks ago |
foodnavigator.com | Donna Eastlake |Augustus Bambridge-Sutton |Flora Southey
From sweets and soft drinks to sandwich spreads and breakfast cereals, sucralose (E955) is used in over 6,000 products worldwide, making it one of the most popular artificial sweeteners on the market. And such is its success, the global sucralose market is now valued at $3.73bn, with a projected CAGR of 5.3% over the next eight years (The Brainy Insights).
-
3 weeks ago |
confectionerynews.com | Donna Eastlake |Augustus Bambridge-Sutton |Flora Southey |Kay Jann
From sweets and soft drinks to sandwich spreads and breakfast cereals, sucralose (E955) is used in over 6,000 products worldwide, making it one of the most popular artificial sweeteners on the market. And such is its success, the global sucralose market is now valued at $3.73bn, with a projected CAGR of 5.3% over the next eight years (The Brainy Insights).
-
2 months ago |
foodnavigator.com | Donna Eastlake |Flora Southey
Misinformation is rife in food and beverage, with inaccurate claims about ingredients, products and production processes, made every single day. And not only can these claims be damaging to the industry, they can also be dangerous to consumers. “Misinformation within this sector is pervasive, with significant consequences for public health and market dynamics,” says Aditi Pangotra, research analyst in policy and advocacy for CyberPeace.
-
Jan 14, 2025 |
outsourcing-pharma.com | Clara Fernandez |Clara Fernández |Flora Southey
Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the deal as one of the largest seen in the pharmaceutical industry in the past year. Founded in 2002, Intra-Cellular Therapies develops innovative treatments for complex psychiatric and neurologic diseases, with a scientific platform based on the work of Nobel Prize winner neuroscientist Paul Greengard.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 391
- Tweets
- 724
- DMs Open
- No
Less than two weeks until FoodNavigator's deep-dive into all things meat and dairy alternatives. Join us in conversation with Garden Gourmet, Oatly, Redefine Meat, Bright Green Partners and more... All-star list of speakers in link! https://t.co/sXvYs1rCg2
How are innovators rethinking packaging? We hear from @HuhtamakiGroup , @FoodBytes and #GreatWrap at #ClimateSmartFood https://t.co/4cn0lyf1hJ
"Plastic has no place in the environment," stressed Ignacio Gavilan from @CGF_The_Forum at the @FoodNavigator #ClimateSmartFood event last week. So how can industry help stem plastic pollution? The CGF and Minna Lyiynen from Refresco Group weigh in https://t.co/7zjr2AN0yK